GBT Commences Research on an External Device for Arterial Clogs and Tissue Imaging Based on its Proprietary Radio Technology
SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is researching an external device for arterial and tissue imaging based on its proprietary radio technology, combined with the company’s robotic research. The research contemplates an external unit targeted to be operated with a robotic arm to scan designated bodily areas and provide an image of arteries and tissues. The main advantage of the contemplated system is its pure non-invasive nature. The research is part of the Hermes capsule research project. The Hermes capsule research targets an intravenous mini-probe unit that travels within the artery, searching to find arterial clogs. Hermes unit is based on radio waves-based imaging to produce a computerized 3D imaging for the operating physician. The unit is contemplated to be AI empowered, non-surgical, minimally invasive, safe method for autonomous and/or manual blood vessels blockage detection and cleaning. The research is focused on developing a complementary unit, which is an external probe is targeted to provide more imaging information for arterial and tissue imaging. The research is examining an external probe that will scan the designated body area that can be mounted on an AI controlled robotic arm, and use radio wave technology to provide 3D imaging of arteries/tissues on a computer screen for a physician review. The research is also evaluating a manually used external probe, as a hand-held unit, similar to typical ultrasound units. The main purpose of the external unit would be to enable external tissue and arterial AI based imaging with great depth and resolution. The external unit will be a combined work of GBT’s medical robotic and Hermes capsule imaging research.
"We are aiming for further advancements for health-related applications and we believe the contemplated external imaging system would add significant advantage, tissue imaging in addition to arterial view. As our Hermes capsule research is targeting to “look ahead” inside arteries, the external device is a combination of our medical robotics and Hermes capsule research to enable a completely non-invasive imaging system, very similar to typical ultrasound units. The research is focused on an external device using radio waves technology that will be transmitted into a designated bodily area for arterial and tissue imaging. Few methods of imaging will be explored to achieve a clear, high resolution 3D shots. It is contemplated as a real time 2D/3D images of the inner blood vessels and tissues using our AI image construction. The system is intended to be able to differ between tissues, organs and clogging materials as well as identifying tumors, Cysts and other foreignobjects. In addition, using the radio technology the system will be able to construct a 3D video imaging of the scanned areas. The probe will be able to be mounted on a robotic arm to hover above designated bodily areas or manually held for more specific areas scan. The system will be using GBT’s AI technology and we strongly believe that it has the potential become a key apparatus within surgery rooms and clinics as a physician’s “eyes” helping savings lives” stated Danny Rittman, GBT’s CTO.
There is no guarantee that the Company will be successful in researching, developing or implementing this system. To successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed, and granted regulatory approval, the Company would need to enter a strategic relationship with a third party that has experience in manufacturing, selling, and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
External Device a conceptual Image.
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Dr. Danny Rittman, CTO
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2166936f-debd-4dd3-bef7-e33d8334216f.
Networking LIVE! Reception - On the Amazing Spacious Seaside Patio of the Loews Miami Beach Resort
Conference Sessions with Lunch
Myth vs. Reality: The Truth About AI and CX